Pharvaris Announces Closing of Initial Public Offering
February 09, 2021 16:05 ET
|
Pharvaris N.V.
ZUG, Switzerland, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris”) (Nasdaq: PHVS), a clinical-stage biopharmaceutical company focused on the discovery, development, and...
Pharvaris Announces Pricing of Upsized Initial Public Offering
February 04, 2021 20:08 ET
|
Pharvaris N.V.
ZUG, Switzerland, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative...